Skip to content

ADAPT-HEAT - Adaption of drug therapy during hot seasons

ADAPT-HEAT - Adaption of drug therapy during hot seasons - ADAPT-HEAT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00033674
Enrollment
70
Registered
2024-09-09
Start date
2024-11-28
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heat-associated health problems

Interventions

Group 1: WP 1.3: Delphi process for the consensus on practical, relevant, and cross-sectorally valid recommendations. Experts will be informed about the upcoming Delphi survey via email, telephone, or

Sponsors

Universitätsklinikum Köln, Institut für Allgemeinmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: AP 1.3: Experts from various disciplines with expertise in drug supply and/or the effects of heat on health. A diversity of professions from inpatient, outpatient, and various specialized care providers, as well as representatives from professional societies and associations, is sought for the composition of the Delphi panel. - All target groups (min. 18 years old) with sufficient physical and mental capacity to participate. - Informed consent after invitation and online information on data protection regulations - Individuals of all genders (m/f/d) and any ethnic background can participate in the Delphi process. AP 2: Adults who are capable of giving consent and who will be involved in clinical practice with patient contact during the study period are recruited. A total of 30 persons should be distributed among the following health professions: - 5 outpatient physicians - 5 inpatient physicians - 5 nurses - 5 medical assistants (MFA) - 5 pharmacists - 5 pharmaceutical technical assistants (PTA) Additional criteria: - informed consent AP 3: 10 Adults who are capable of giving informed consent will be recruited — individuals who, during the study period, are receiving primary care treatment for one or more chronic conditions and are taking one or more medications on the CALOR list. Additional criteria: - informed consent

Exclusion criteria

Exclusion criteria: AP 1.3: Insufficient German language skills for participation in the study. AP 2: Planned end of employment during the study period. Insufficient German language skills for participation in the study. AP 3: Cognitive limitations that prevent participation in the study. Insufficient German language skills for study participation. A professional medical background that would lead to a distortion of the lay perspective.

Design outcomes

Primary

MeasureTime frame
Development of evidence-based, consensus-based, cross-sectoral recommendations for heat-sensitive medication adjustments to prevent heat-related health disorders.

Countries

Germany

Contacts

Public ContactMaxie Bunz

Universitätsklinikum Köln, Institut für Allgemeinmedizin

maxie.bunz@uk-koeln.de+49 221 478-96253

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026